MICOT PHARMA-B

02335
20.5805.07% ( -1.100 )
Delay Closed: Nov 13, 16:08:17

Valuation

Current ValuationThe current P/E ratio is -16.27, above the reasonable range, cheaper than 17.48% of the time in the past 1 years, and the industry ranks 56/78, the industry Median -5.30.

-16.27xP/E
Stock priceHK$20.58Earnings per shareHK$-1.26

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0154308462616

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-69.56x75.50%HK$77.46B
09688HKZAI LAB
-16.36x17.69%HK$25.47B
01877HKJUNSHI BIO
-33.41x83.59%HK$15.35B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
06855HKASCENTAGE
-6.23x19.11%HK$10.54B
07666HKMETIS TECHBIO-P
-24.29x96.67%HK$9.89B
09606HKDUALITYBIO-B
-5.62x85.35%HK$9.30B
01952HKEVEREST MED
-145.90x326.79%HK$9.06B
02616HKCSTONE PHARMA-B
-17.22x1.09%HK$8.31B
02595HKGENFLEET-B
-5.45x66.07%HK$8.26B
02493HKMABWELL-B
-6.50x--HK$7.95B
06938HKRIBOLIFE-B
-37.27x29.56%HK$7.28B
09887HKLEADS BIOLABS-B
-22.73x3.57%HK$6.99B
02335HKMICOT PHARMA-B
-16.27x37.52%HK$6.83B
02171HKCARSGEN-B
-60.42x52.33%HK$6.20B
09966HKALPHAMAB-B
-27.37x--HK$5.54B
00775HKCKLIFE SCIENCES
-79.47x--HK$5.14B
01672HKASCLETIS-B
-7.25x78.53%HK$4.94B
02256HKABBISKO-B
-9.05x814.43%HK$4.86B
01779HKLONGBIO-B
-18.23x--HK$4.54B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.